Cadila Healthcare has entered into a share subscription agreement (SSA) with Zydus Wellness (ZWL), a subsidiary Company, to subscribe to 85,02,170 equity shares at an issue price of Rs 1,382 amounting to Rs 1174.99 crore.
Cadila Healthcare is an India-based pharmaceutical company. The company’s subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.